Page 1

24 February 2021 Manager , Company Announcements ASX Limited Level 4 20 Bridge Street SYDNEY NSW 2000 Via E - Lodgement Mayne Pharma Group Limited Media release for the half year ended 31 December 2020 In accordance with the Listing Rules , I attach a market release , for immediate release to the market . Mayne Pharma will host an investor and analyst webcast and conference commencing at 9.00am ( AEST ) on 24 February 2021. Links to register for the conference are provided below . A replay of the presentation will also be available on the website www.maynepharma.com from approximately 1pm AEDT . For the purposes of ASX Listing Rule 15.5 , Mayne Pharma confirms that this document has been authorised for release to the market by the Board . Links to register for teleconference : https://wsw.com/webcast/cc/myx.ax13/ Yours faithfully Dauna @ Roft Laura Loftus Company Secretary For further information , please contact Lisa Pendlebury VP Investor Relations & Communications Phone : +61 419 548 434 Email : lisa.pendlebury@maynepharma.com mayne pharma Mayne Pharma Group Limited ABN 76 115 832 963 maynepharma.com T +61 8 8209 2666 F +61 8 8281 0284 1538 Main North Road , Salisbury South , SA 5106 Australia PO Box 700 , Salisbury , SA 5108 Australia